Elmar Kraus

Stock Analyst at DZ Bank

(2.92)
# 1,563
Out of 4,941 analysts
12
Total ratings
80%
Success rate
25.75%
Average return

Stocks Rated by Elmar Kraus

Eli Lilly and Company
Feb 21, 2024
Downgrades: Hold
Price Target: $820
Current: $639.43
Upside: +28.24%
GSK plc
Feb 11, 2022
Downgrades: Hold
Price Target: n/a
Current: $38.22
Upside: -
AstraZeneca
Feb 11, 2022
Upgrades: Hold
Price Target: n/a
Current: $75.34
Upside: -
Pfizer
Feb 4, 2021
Upgrades: Buy
Price Target: $41
Current: $24.65
Upside: +66.33%
Medtronic
May 14, 2020
Downgrades: Hold
Price Target: $92
Current: $92.08
Upside: -0.09%
Gilead Sciences
Mar 18, 2020
Upgrades: Buy
Price Target: n/a
Current: $120.02
Upside: -